Current treatment of opportunistic infections in HIV disease.
Bagdades
E K
EK
Department of Thoracic Medicine, Royal Free Hospital, London, UK.
D000890:Anti-Infective Agents / Q000627:therapeutic use; D002177:Candidiasis / Q000517:prevention & control / Q000628:therapy; D003457:Cryptosporidiosis / Q000517:prevention & control / Q000628:therapy; D003586:Cytomegalovirus Infections / Q000517:prevention & control / Q000628:therapy; D015658:HIV Infections / Q000150:complications / Q000517:prevention & control / Q000628:therapy*; D006801:Humans; D016919:Meningitis, Cryptococcal / Q000517:prevention & control / Q000628:therapy; D009165:Mycobacterium Infections, Nontuberculous / Q000517:prevention & control / Q000628:therapy; D009894:Opportunistic Infections / Q000150:complications / Q000517:prevention & control / Q000628:therapy*; D011020:Pneumonia, Pneumocystis / Q000517:prevention & control / Q000628:therapy; D014123:Toxoplasmosis / Q000517:prevention & control / Q000628:therapy
D000890:Anti-Infective Agents